These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1846070)

  • 61. Alterations in plasma and tumour levels of fatty acids with weight loss in an experimental cachexia model.
    Hudson EA; Tisdale MJ
    Prostaglandins Leukot Essent Fatty Acids; 1994 May; 50(5):229-34. PubMed ID: 8066096
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid.
    Rahman MM; Bhattacharya A; Fernandes G
    J Cell Physiol; 2008 Jan; 214(1):201-9. PubMed ID: 17929247
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Eicosapentaenoic acid and oxypurinol in the treatment of muscle wasting in a mouse model of cancer cachexia.
    Vaughan VC; Sullivan-Gunn M; Hinch E; Martin P; Lewandowski PA
    PLoS One; 2012; 7(9):e45900. PubMed ID: 23029301
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Eicosapentaenoic acid ethyl ester supplementation in cachectic cancer patients and healthy subjects: effects on lipolysis and lipid oxidation.
    Zuijdgeest-Van Leeuwen SD; Dagnelie PC; Wattimena JL; Van den Berg JW; Van der Gaast A; Swart GR; Wilson JH
    Clin Nutr; 2000 Dec; 19(6):417-23. PubMed ID: 11104593
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential effects of eicosapentaenoic acid and docosahexaenoic acid in promoting the differentiation of 3T3-L1 preadipocytes.
    Murali G; Desouza CV; Clevenger ME; Ramalingam R; Saraswathi V
    Prostaglandins Leukot Essent Fatty Acids; 2014 Jan; 90(1):13-21. PubMed ID: 24332315
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
    Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
    Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Weight loss in tumour-bearing mice is not associated with changes in resistin gene expression in white adipose tissue.
    Gómez-Ambrosi J; Zabalegui N; Bing C; Tisdale MJ; Trayhurn P; Williams G
    Horm Metab Res; 2002; 34(11-12):674-7. PubMed ID: 12660881
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characterization of a cancer cachectic factor.
    Todorov P; Cariuk P; McDevitt T; Coles B; Fearon K; Tisdale M
    Nature; 1996 Feb; 379(6567):739-42. PubMed ID: 8602222
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evidence for a novel serum factor distinct from zinc alpha-2 glycoprotein that promotes body fat loss early in the development of cachexia.
    Byerley LO; Lee SH; Redmann S; Culberson C; Clemens M; Lively MO
    Nutr Cancer; 2010; 62(4):484-94. PubMed ID: 20432169
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular analysis of lipid-depleting factor in a colon-26-inoculated cancer cachexia model.
    Inadera H; Nagai S; Dong HY; Matsushima K
    Int J Cancer; 2002 Sep; 101(1):37-45. PubMed ID: 12209586
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cancer cachexia.
    Tisdale MJ
    Langenbecks Arch Surg; 2004 Aug; 389(4):299-305. PubMed ID: 15168125
    [TBL] [Abstract][Full Text] [Related]  

  • 72. DHA effect on chemotherapy-induced body weight loss: an exploratory study in a rodent model of mammary tumors.
    Hajjaji N; Couet C; Besson P; Bougnoux P
    Nutr Cancer; 2012; 64(7):1000-7. PubMed ID: 23035949
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prepartum fatty acid supplementation in sheep. II. Supplementation of eicosapentaenoic acid and docosahexaenoic acid during late gestation alters the fatty acid profile of plasma, colostrum, milk and adipose tissue, and increases lipogenic gene expression of adipose tissue.
    Coleman DN; Murphy KD; Relling AE
    J Anim Sci; 2018 Apr; 96(3):1181-1204. PubMed ID: 29365116
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Eicosapentaenoic acid supplementation reduces tumor volume and attenuates cachexia in a rat model of progressive non-metastasizing malignancy.
    Jho DH; Babcock TA; Tevar R; Helton WS; Espat NJ
    JPEN J Parenter Enteral Nutr; 2002; 26(5):291-7. PubMed ID: 12216709
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients.
    Groundwater P; Beck SA; Barton C; Adamson C; Ferrier IN; Tisdale MJ
    Br J Cancer; 1990 Nov; 62(5):816-21. PubMed ID: 2245173
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lack of effect of eicosapentaenoic acid in preventing cancer cachexia and inhibiting tumor growth.
    Costelli P; Llovera M; López-Soriano J; Carbó N; Tessitore L; López-Soriano FJ; Baccino FM; Argilés JM
    Cancer Lett; 1995 Oct; 97(1):25-32. PubMed ID: 7585474
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Divergent effects of eicosapentaenoic and docosahexaenoic acid ethyl esters, and fish oil on hepatic fatty acid oxidation in the rat.
    Hong DD; Takahashi Y; Kushiro M; Ide T
    Biochim Biophys Acta; 2003 Nov; 1635(1):29-36. PubMed ID: 14642774
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The influence of eicosapentaenoic acid and docosahexaenoic acid on expression of genes connected with metabolism and secretory functions of ageing 3T3-L1 adipocytes.
    Prostek A; Gajewska M; Bałasińska B
    Prostaglandins Other Lipid Mediat; 2016 Sep; 125():48-56. PubMed ID: 27166928
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evidence that changes in Se-glutathione peroxidase levels affect the sensitivity of human tumour cell lines to n-3 fatty acids.
    Schønberg SA; Rudra PK; Nøding R; Skorpen F; Bjerve KS; Krokan HE
    Carcinogenesis; 1997 Oct; 18(10):1897-904. PubMed ID: 9363997
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice.
    van Norren K; Kegler D; Argilés JM; Luiking Y; Gorselink M; Laviano A; Arts K; Faber J; Jansen H; van der Beek EM; van Helvoort A
    Br J Cancer; 2009 Mar; 100(5):713-22. PubMed ID: 19259092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.